Literature DB >> 19050279

Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.

Joshua S Woodworth1, Ying Wu, Samuel M Behar.   

Abstract

Optimal immunity to Mycobacterium tuberculosis (Mtb) infection requires CD8(+) T cells, and several current Mtb vaccine candidates are being engineered to elicit enhanced CD8(+) T cell responses. However, the function of these T cells and the mechanism by which they provide protection is still unknown. We have previously shown that CD8(+) T cells specific for the mycobacterial Ags CFP10 and TB10.4 accumulate in the lungs of mice following Mtb infection and have cytolytic activity in vivo. In this study, we determine which cytolytic pathways are used by these CD8(+) T cells during Mtb infection. We find that Mtb-specific CD8(+) T cells lacking perforin have reduced cytolytic capacity in vivo. In the absence of perforin, the residual cytolytic activity is CD95 and TNFR dependent. This is particularly true in Mtb-infected lung tissue where disruption of both perforin and CD95 eliminates target cell lysis. Moreover, adoptive transfer of immune CD8(+) T cells isolated from wild-type, but not perforin-deficient mice, protect recipient mice from Mtb infection. We conclude that CD8(+) T cells elicited following Mtb infection use several cytolytic pathways in a hierarchical and compensatory manner dominated by perforin-mediated cytolysis. Finally, although several cytolytic pathways are available, adoptively transferred Mtb-specific CD8(+) T cells require perforin-mediated cytolysis to protect animals from infection. These data show that CD8(+) T cell-mediated protection during Mtb infection requires more than the secretion of IFN-gamma and specifically defines the CD8(+) cytolytic mechanisms utilized and required in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050279      PMCID: PMC3133658          DOI: 10.4049/jimmunol.181.12.8595

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  Progress in tuberculosis vaccine development.

Authors:  Sven Baumann; Ali Nasser Eddine; Stefan H E Kaufmann
Journal:  Curr Opin Immunol       Date:  2006-06-13       Impact factor: 7.486

2.  Tuberculosis vaccines - an update.

Authors:  Peter Andersen
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

3.  Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.

Authors:  T Stalder; S Hahn; P Erb
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

4.  Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection.

Authors:  Arati Kamath; Joshua S M Woodworth; Samuel M Behar
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

5.  CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.

Authors:  Deborah M Brown; Allison M Dilzer; Dana L Meents; Susan L Swain
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 6.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

7.  Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection.

Authors:  Ying Wu; Joshua S Woodworth; Daniel S Shin; Sheldon Morris; Samuel M Behar
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

8.  Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.

Authors:  Jan Andersson; Arina Samarina; Joshua Fink; Sayma Rahman; Susanna Grundström
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

9.  Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1.

Authors:  Rolf Billeskov; Carina Vingsbo-Lundberg; Peter Andersen; Jes Dietrich
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 10.  Next generation: tuberculosis vaccines that elicit protective CD8+ T cells.

Authors:  Samuel M Behar; Joshua S M Woodworth; Ying Wu
Journal:  Expert Rev Vaccines       Date:  2007-06       Impact factor: 5.217

View more
  71 in total

1.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

2.  Identification and analysis of exosomes secreted from macrophages extracted by different methods.

Authors:  Jianjun Wang; Yongliang Yao; Jianhong Wu; Guangxin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.

Authors:  Shihoko Komine-Aizawa; Jiansheng Jiang; Satoru Mizuno; Satoshi Hayakawa; Kazuhiro Matsuo; Lisa F Boyd; David H Margulies; Mitsuo Honda
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

Review 4.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

5.  Decreased expression of perforin in CD8+ T lymphocytes in patients with Mycobacterium tuberculosis infection and its potential value as a marker for efficacy of treatment.

Authors:  Hongbin Jiang; Huili Gong; Qing Zhang; Jin Gu; Li Liang; Jun Zhang
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

6.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

7.  Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Luke Elizabeth Hanna; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2014-07-01       Impact factor: 3.131

8.  Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair.

Authors:  Maziar Divangahi; Minjian Chen; Huixian Gan; Danielle Desjardins; Tyler T Hickman; David M Lee; Sarah Fortune; Samuel M Behar; Heinz G Remold
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

Review 9.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

10.  Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.

Authors:  Edward O Ronan; Lian Ni Lee; Peter C L Beverley; Elma Z Tchilian
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.